PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

DOE announces $46 million for commercial fusion energy development

8 Companies across 7 states will receive funding to help solidify U.S. leadership in developing clean energy from fusion

2023-06-01
(Press-News.org) WASHINGTON, D.C.—The U.S. Department of Energy (DOE) today announced $46 million in funding to eight companies advancing designs and research and development for fusion power plants, representing a major step in President Biden’s commitment to a pilot-scale demonstration of fusion within a decade. Fusion reactions power the stars, and research is underway to make fusion energy production on Earth possible, providing an abundant, inherently safe, non-carbon-emitting energy source for the planet. This funding from the Milestone-Based Fusion Development Program will solidify U.S. leadership in fusion commercialization, a gamechanger that would help the United States meet the President’s goal of reaching a net-zero economy by 2050.

“We have generated energy by drawing power from the sun above us. Fusion offers the potential to create the power of the sun right here on Earth,” said U.S. Secretary of Energy Jennifer Granholm. “The Biden-Harris Administration is committed to partnering with innovative researchers and companies across the country to take fusion energy past the lab and toward the grid.”

“Fusion is a promising technology with the potential to play a transformative role in meeting the urgent need for reliable, carbon-free energy to power our country,” said U.S. Senator Patty Murray (WA). “It’s exciting to see Washington state once again playing a leading role in the development of clean energy technologies and innovative solutions to help us tackle the climate crisis, and this award will help propel Zap Energy’s fusion research in Everett and Mukilteo.”

“Today marks a pivotal point for advancing U.S. commercial fusion technology with the announcement of the first selections for the new Milestone-Based Fusion Development Program. With the passage of the Energy Act of 2020 and the CHIPS and Science Act of 2022, Congress provided clear bipartisan direction and support for the Department of Energy to undertake an ambitious program to develop fusion technologies to be commercially deployable in the next ten years. I am genuinely excited by the potential of fusion energy and technology to transform our future and contribute to our energy and national security,” said U.S. Senator Joe Manchin (WV), Chairman of the U.S. Senate Committee on Energy and Natural Resources.  

“I am very pleased to see this innovative public-private partnership program move forward. This was one of the key fusion energy provisions developed by the House Science, Space, and Technology Committee—first authorized in the bipartisan Energy Act of 2020 and extended in the CHIPS and Science Act. These awards will address some of the most critical challenges to the commercialization of fusion energy, and I would like to congratulate all of the awardees for their impressive achievements to date. But we certainly can’t stop here. The recent progress and promise of fusion energy warrant our full support for all of the important fusion energy activities that Congress has enacted and the President has proposed for Fiscal Year 2024, and I will continue to do everything I can to meet that goal,” said U.S. Representative Zoe Lofgren (CA-18), Ranking Member of the U.S. House Committee on Science, Space, and Technology.  

“Commercial fusion energy will revolutionize the energy industry. As the Chairman of the Appropriations Subcommittee on Energy and Water Development and Co-Chairman of the Congressional Fusion Caucus, I am proud to support funding that blends the scientific and technological expertise of the Office of Science and its national laboratories with the innovative approach of the private sector. This is a major step to developing commercial fusion energy that will transform how America meets its energy needs and make our nation the global leader in fusion energy science and technology,” said U.S. Representative Chuck Fleischmann (TN-3), Chairman of the U.S. House Committee on Appropriations Subcommittee on Energy and Water Development.  

 “I am glad to see the Milestone-Based Fusion Development Program begin its second year of building critical partnerships aimed at bringing fusion energy from our laboratories to powering our homes,” said U.S. Representative Don Beyer (VA-8). “This program presents a remarkable opportunity to harness the combined strength of the U.S. fusion private sector community and the nation's energy leaders to increase the potential of fusion energy and transform the global energy sector. This collaboration is yet another big win for fusion energy. I commend the Department of Energy for its leadership and vision in supporting this program again and look forward to what the program can help us accomplish.” 

“When I first put pen to paper drafting the Milestone-Based Fusion Development Program three years ago, I had today’s announcement in mind,” said U.S. Representative Lori Trahan (MA-3), Co-Chair of the bipartisan Congressional Fusion Caucus. “Eight companies, including Commonwealth Fusion Systems right here in Massachusetts, are leading the cutting-edge work being done across the United States to win the race to finally commercialize fusion energy. I’m proud to see this funding being deployed to bolster those efforts, and I look forward to working with Secretary Granholm, members of the bipartisan Congressional Fusion Caucus, and our remarkable researchers to ensure this federal support continues until we unlock this limitless source of clean energy.”

Within five to 10 years, the eight awardees will resolve scientific and technological challenges to create designs for a fusion pilot plant that will help bring fusion to both technical and commercial viability. This program was partially inspired by the National Aeronautics and Space Administration’s Commercial Orbital Transportation Services program that helped enable commercial space launch.

The awardees are as follows:

Commonwealth Fusion Systems (Cambridge, MA) Focused Energy Inc. (Austin, TX) Princeton Stellarators Inc. (Branchburg, NJ) Realta Fusion Inc. (Madison, WI) Tokamak Energy Inc. (Bruceton Mills, WV) Type One Energy Group (Madison, WI) Xcimer Energy Inc. (Redwood City, CA) Zap Energy Inc. (Everett, WA) This funding is a major step to meeting the Biden Harris Administration’s goals laid out at the March 2022 White House summit on Developing a Bold Decadal Vision for Commercial Fusion Energy.

In December, researchers at DOE’s Lawrence Livermore National Laboratory achieved fusion ignition and generated more energy from fusion than the input energy to the fuel target. This showed that fusion is a possible source of clean energy for humanity and that fusion science has reached a level of maturity to support the premise of that vision to accelerate efforts in the engineering development of a fusion pilot plant.

Applicants for these awards—selected by competitive peer review under the DOE Funding Opportunity Announcement for the Milestone-Based Fusion Development Program—went through a rigorous merit-review process that included evaluation of their scientific, technical, commercialization, and business and financial viabilities. The review also looked at the companies’ plans to support DOE’s efforts in advancing President Biden’s Justice40 Initiative, whose goal is that 40 percent of the overall benefits of certain climate and energy investments flow to disadvantaged communities.

The total funding of $46 million is for the first 18 months, with funds coming from Fiscal Years 2022 and 2023. Projects may last up to five years in duration, with outyear funding contingent on congressional appropriations, and continued participation from the teams contingent on satisfactory progress in meeting the negotiated milestones.

 

Watch the announcement of the funding by Secretary Granholm and White House Office of Science and Technology Policy Director Arati Prabhakar here.

More information about the projects can be found on the Fusion Energy Sciences Topical Funding Opportunity Awards page.

 

END


ELSE PRESS RELEASES FROM THIS DATE:

More than 1 in 6 unvaccinated people report health effects of COVID two years after confirmed infection

2023-06-01
Around 1 in 6 unvaccinated individuals say they are still experiencing health effects of covid-19 up to two years after infection, finds a study from Switzerland published by The BMJ today. The findings show that 17% of participants did not return to normal health and 18% reported covid-19 related symptoms 24 months after initial infection. Most people who have covid-19 recover soon after the initial phase of the disease, but others experience persistent health problems (known as long covid), which can impact quality of life ...

Improving emergency, critical and operative care in low and middle-income countries

2023-06-01
DALLAS and GENEVA, May 31, 2023 — Global efforts to improve emergency, critical and operative care for universal health coverage and protection from health emergencies were announced at the 76th World Health Assembly in Geneva, Switzerland. With the support of its partners the American Heart Association and the Laerdal Foundation, the World Health Organization (WHO), announced an initiative based on a new acute care resolution that was approved at this year’s World Health Assembly, the decision-making body of WHO. Nearly 30 million deaths are due to emergency conditions each year, contributing to half of global deaths. The acute ...

Huntsman Cancer Institute May research highlights

Huntsman Cancer Institute May research highlights
2023-06-01
Huntsman Cancer Institute research highlights shine the spotlight on new discoveries and cutting-edge cancer research. This past month, researchers found a better treatment practice for patients who have melanoma. They also created a model for adrenocortical carcinoma, a rare cancer that originates in the outer portion of the adrenal gland. Learn more about a new brain cancer medication being fast-tracked for FDA approval and how Huntsman Cancer Institute was selected to conduct clinical trials for cancer patients with HIV. Clinical trial suggests changes to melanoma patient care A study recounting a clinical trial published ...

Postdoctoral research experience gets major boost at Pennington Biomedical

Postdoctoral research experience gets major boost at Pennington Biomedical
2023-06-01
Former Pennington Biomedical Research Center Executive Director Dr. Claude Bouchard and his wife, Monique Chagnon, were celebrated at a luncheon on Tuesday, May 30, for their generous gift to enhance the postdoctoral researcher experience at Pennington Biomedical. As one of the world’s foremost researchers in the genetics of obesity and related diseases, including type 2 diabetes and hypertension, the Bouchard laboratory has trained about 40 postdoctoral researchers throughout his career. “I became very conscious that postdocs are critical to the success of the scientific research enterprise. They work hard, they ...

New liver dialysis device shows potential to resolve liver failure in patients with acute-on-chronic liver failure

New liver dialysis device shows potential to resolve liver failure in patients with acute-on-chronic liver failure
2023-06-01
Amsterdam, June 1, 2023 – Acute-on-chronic liver failure (ACLF) occurs in 30% of hospitalized cirrhosis patients, leading to over one million deaths worldwide each year. Currently the only potential treatment for this condition is liver transplantation, which is available to very few patients. A first-in-human randomized controlled clinical trial using DIALIVE, a novel liver dialysis device, demonstrated its potential as a disease-modifying therapy and resolved liver failure significantly faster and in a greater proportion of patients ...

Liver dialysis device proved safe and effective for treating severe liver failure

2023-06-01
The first successful in-patient trial of liver dialysis* has been completed by researchers from UCL, the Royal Free Hospital, UCL spin-out Yaqrit and their collaborators. The DIALIVE device, invented by researchers at UCL’s Institute for Liver and Digestive Health, was found to be safe and was associated with substantial improvement in the severity of symptoms and organ function in a greater proportion of patients with acute-on-chronic liver failure (ACLF), when compared with patients receiving standard of care. The next step will be a larger clinical trial, which if successful could see DIALIVE approved for clinical use within the next three years. Worldwide, it is estimated that there ...

Xrays reveal ancient secrets about our prehistoric world this World Dinosaur Day

2023-06-01
Researchers are shedding light on our ancient prehistoric world using state-of-the art Xray technology. This World Dinosaur Day, scientists are sharing the bones which lay beneath the Harbury Icthyosau – providing clues to dinosaur anatomy, physiology and evolution. The University's of Warwick’s Centre for Imaging, Metrology and Additive Technologies (CiMAT) group at WMG has employed its cutting-edge equipment to explore the anatomy and biology of the Harbury Icthyosaur, a large marine reptile which lived on the Earth hundreds of millions of years ...

Phototherapy device has potential to be a novel treatment for sleep complaints

Phototherapy device has potential to be a novel treatment for sleep complaints
2023-05-31
DARIEN, IL – Wearing a phototherapy device that emits near-infrared light is associated with potential therapeutic benefits for sleep and daytime functioning, according to a new study to be presented at the SLEEP 2023 annual meeting. Results show that self-reported, sleep-related symptoms improved after three weeks of treatment. Participants in the active treatment group reported experiencing better sleep quality, feeling more refreshed and relaxed, and functioning better during the day. “This novel phototherapy device — while ...

UC Irvine-led interdisciplinary team delves into a heated debate about humidity

2023-05-31
Irvine, Calif., May 31, 2023 – As climate change increases the severity, frequency and duration of heat waves around the world, researchers at the University of California, Irvine and other institutions are sounding an alarm about what they consider to be an added threat to human health: humidity. Heat extremes increase the risk of illness and death, with the worst outcomes among people who are older, have chronic diseases, live in hot climates and are socioeconomically disadvantaged. In addition, humidity causes heat stress by making it harder for bodies to cool, but medical and public health experts still disagree about ...

Level of support for gender-neutral option on state IDs affected by political orientation, social context

2023-05-31
Key takeaways As of June, 22 U.S. states and the District of Columbia will offer the opportunity for residents to select a gender-neutral marker on government-issued IDs. UCLA sociologist Abigail Saguy found that LGBTQ+ and feminist activists support both the addition of a gender-neutral option and the removal of gender identifiers on IDs. Conservative activists oppose both measures. As of June, 22 states and the District of Columbia will allow residents to select a gender-neutral “X” marker, rather than “male” or “female,” on their driver’s licenses, ...

LAST 30 PRESS RELEASES:

Experts call for global genetic warning system to combat the next pandemic and antimicrobial resistance

Genetic variations may predispose people to Parkinson’s disease following long-term pesticide exposure, study finds

Deer are expanding north, and that’s not good for caribou

Puzzling link between depression and cardiovascular disease explained at last: they partly develop from the same gene module

Synthetic droplets cause a stir in the primordial soup

Future parents more likely to get RSV vaccine when pregnant if aware that RSV can be a serious illness in infants

Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1

The Lundquist Institute receives $2.6 million grant from U.S. Army Medical Research Acquisition Activity to develop wearable biosensors

Understanding the cellular mechanisms of obesity-induced inflammation and metabolic dysfunction

Study highlights increased risk of second cancers among breast cancer survivors

International DNA Day launch for Hong Kong’s Moonshot for Biology

New scientific resources map food components to improve human and environmental health

Mass General Brigham research identifies pitfalls and opportunities for generative artificial intelligence in patient messaging systems

Opioids during pregnancy not linked to substantially increased risk of psychiatric disorders in children

Universities and schools urged to ban alcohol industry-backed health advice

From Uber ratings to credit scores: What’s lost in a society that counts and sorts everything?

Political ‘color’ affects pollution control spending in the US

Managing meandering waterways in a changing world

Expert sounds alarm as mosquito-borne diseases becoming a global phenomenon in a warmer more populated world

Climate change is multiplying the threat caused by antimicrobial resistance

UK/German study - COVID-19 vaccine effectiveness and fewer common side-effects most important factors in whether adults choose to get vaccinated

New ultraviolet light air disinfection technology could help protect against healthcare infections and even the next pandemic

Major genetic meta-analysis reveals how antibiotic resistance in babies varies according to mode of birth, prematurity, and where they live

Q&A: How TikTok’s ‘black box’ algorithm and design shape user behavior

American Academy of Arts and Sciences elects three NYU faculty as 2024 fellows

A closed-loop drug-delivery system could improve chemotherapy

MIT scientists tune the entanglement structure in an array of qubits

Geologists discover rocks with the oldest evidence yet of Earth’s magnetic field

It’s easier now to treat opioid addiction with medication -- but use has changed little

Researchers publish final results of key clinical trial for gene therapy for sickle cell disease

[Press-News.org] DOE announces $46 million for commercial fusion energy development
8 Companies across 7 states will receive funding to help solidify U.S. leadership in developing clean energy from fusion